BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26919325)

  • 1. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
    Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
    Menesy A; Hammad M; Aref S; Abozeid FAM
    BMC Gastroenterol; 2024 Apr; 24(1):135. PubMed ID: 38622545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
    Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
    World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD.
    Boyapati RK; Dorward DA; Tamborska A; Kalla R; Ventham NT; Doherty MK; Whitfield PD; Gray M; Loane J; Rossi AG; Satsangi J; Ho GT
    Inflamm Bowel Dis; 2018 Sep; 24(10):2113-2122. PubMed ID: 29718255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
    Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
    Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?
    Gravina AG; Panarese I; Trotta MC; D'Amico M; Pellegrino R; Ferraraccio F; Galdiero M; Alfano R; Grieco P; Federico A
    World J Gastroenterol; 2024 Mar; 30(9):1132-1142. PubMed ID: 38577176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
    Yarur AJ; Bruss A; Moosreiner A; Beniwal-Patel P; Nunez L; Berens B; Colombel JF; Targan SR; Fox C; Melmed GY; Abreu MT; Deepak P
    Gastroenterology; 2023 Oct; 165(4):963-975.e5. PubMed ID: 37499955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device.
    Shahub S; Kumar RM; Lin KC; Banga I; Choi NK; Garcia NM; Muthukumar S; Rubin DT; Prasad S
    Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38520737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease.
    Bohra A; Batt N; Dutt K; Lewis D; Segal JP; Newiadomski O; Vasudevan A; Langenberg DRV
    Therap Adv Gastroenterol; 2024; 17():17562848241237895. PubMed ID: 38486818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the Gut Mycobiome in Patients With Ulcerative Colitis.
    Jangi S; Hsia K; Zhao N; Kumamoto CA; Friedman S; Singh S; Michaud DS
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):821-830.e7. PubMed ID: 37802272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibroblast growth factor 19 level correlates inversely with clinical and endoscopic activity of inflammatory bowel disease.
    Łukawska A; Mulak A
    Adv Clin Exp Med; 2024 Mar; ():. PubMed ID: 38530319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease.
    Heydari R; Karimi P; Meyfour A
    Biomed Pharmacother; 2024 Jul; 176():116868. PubMed ID: 38850647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review.
    Majidova K; Handfield J; Kafi K; Martin RD; Kubinski R
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Autoimmune Protocol Diet Improves Patient-Reported Quality of Life in Inflammatory Bowel Disease.
    Chandrasekaran A; Groven S; Lewis JD; Levy SS; Diamant C; Singh E; Konijeti GG
    Crohns Colitis 360; 2019 Oct; 1(3):otz019. PubMed ID: 31832627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply.
    Aliu A; Bosch DHCA; Keszthelyi D; Ardabili AR; Colombel JF; Sawyer R; Törnblom H; Hart A; Jonkers DMAE; Pierik MJ; Mujagic Z
    Aliment Pharmacol Ther; 2024 Jun; 59(12):1646-1647. PubMed ID: 38726864
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease.
    Logan M; MacKinder M; Clark CM; Kountouri A; Jere M; Ijaz UZ; Hansen R; McGrogan P; Russell RK; Gerasimidis K
    BMC Gastroenterol; 2022 May; 22(1):260. PubMed ID: 35606704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Physiologic Significance of Early Urinary Intestinal Fatty Acid Binding Protein Levels in Preterm Infants: A Prospective Cohort Study.
    Jung YH; Kim EK; Shin SH; Lee JA; Kim HS; Kim BI
    Children (Basel); 2021 Sep; 8(10):. PubMed ID: 34682107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation.
    Vanuytsel T; Tack J; Farre R
    Front Nutr; 2021; 8():717925. PubMed ID: 34513903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pilot Study Evaluating Novel Urinary Biomarkers for Crohn's Disease.
    Ho SS; Wall C; Gearry RB; Keenan J; Day AS
    Inflamm Intest Dis; 2020 Nov; 5(4):212-220. PubMed ID: 33313074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update.
    Linsalata M; Riezzo G; Clemente C; D'Attoma B; Russo F
    Dis Markers; 2020; 2020():2886268. PubMed ID: 33110455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.